-
Q&A: Prescription drug ads are everywhere. Is the 'ask your doctor' era over?
It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug... Read more -
Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications
Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or... Read more -
Novel delivery method bypasses blood-brain barrier to treat ALS symptoms
A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic... Read more -
Antibody developed to protect immune system cells in vitro from a dangerous hospital-acquired bacterium
A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC),... Read more -
FDA approves Dupixent for allergic fungal rhinosinusitis
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6... Read more -
Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes
An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk... Read more -
Starving cancer: The effects of nutrient deprivation on synovial sarcoma
Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults. While it can... Read more -
Study identifies erythropoietin as a potential active ingredient in Primrose syndrome
A research team from Mannheim, Göttingen, Varna, and Princeton has discovered in animal studies with mice that the growth factor... Read more -
New GLP-1 pill orforglipron outperforms oral semaglutide in yearlong diabetes trial
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a... Read more -
Aspirin not a quick fix for preventing bowel cancer, review finds
Daily aspirin use does not offer a quick or reliable way to prevent bowel cancer in the general population and... Read more -
Many post-authorization studies fail to comply with public disclosure rules
Many post-authorization studies registered with the European Medicines Agency (EMA) fail to comply with legal requirements and recommendations to make... Read more -
Single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens
A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more... Read more -
Opioids aren't effective for many acute pain conditions, researchers warn
A large review of opioid pain relievers prescribed for acute pain has found these medicines provide only small, short-term relief... Read more -
Lifespan-extending treatments increase variation in age at time of death
A key goal in aging research is not just to extend life, but to ensure more people live longer and... Read more -
Natural compound from pomegranate leaves disrupts disease-causing amyloid
A research team at Kumamoto University has discovered that a natural compound found in pomegranate leaves and branches can directly... Read more
